cytarabine has been researched along with dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lönn, S; Lönn, U | 1 |
1 other study(ies) available for cytarabine and dichlorobis(1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole)platinum (ii)
Article | Year |
---|---|
Treatment with dilute alkali-nuclease S1 permits the analysis of DNA damage: cells treated with platinum analogues.
Topics: Cell Line; Cisplatin; Cytarabine; DNA Damage; DNA Replication; DNA, Neoplasm; Endonucleases; Humans; Isomerism; Kinetics; Melanoma; Metronidazole; Organoplatinum Compounds; Single-Strand Specific DNA and RNA Endonucleases; Thiourea | 1987 |